← Open Payments lookup

JILL DAVIS: Open Payments

NPI 1316330988 · LEAVENWORTH, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,105 in 107 payments from 11 companies in 2025. Trend: 2023 $1,088 · 2024 $780 · 2025 $2,105

Food & beverage: $1,994Education: $111
CompanyPaymentsAmount
ABBVIE INC.20$313
Neurocrine BioSciences, Inc.8$311
Otsuka America Pharmaceutical, Inc.15$272
Vanda Pharmaceuticals Inc.10$253
Alkermes, Inc.14$214
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$211
Teva Pharmaceuticals USA, Inc.7$184
E.R. Squibb & Sons, L.L.C.9$157
Janssen Pharmaceuticals, Inc5$117
Lundbeck LLC2$42

Products named: VRAYLAR, INGREZZA, CAPLYTA, ARISTADA, HETLIOZ, COBENFY, ABILIFY ASIMTUFII, REXULTI.

Industry payments across KS — which companies pay providers there.